Views & Analysis Dr. B: Expanding the business model from COVID vaccines to a... Cyrus Massoumi, founder of Dr.
Market Access UK life science competitiveness indicators 2022: measuring w... The latest life science competitiveness indicators (LSCIs
Market Access Why reshoring drug production means embracing continuous man... Recent history should have the pharmaceutical industry questioning some of its fundamental assumptions.
Market Access Philips on designing innovation and cultivating partnerships... This article follows part one of our
Market Access Global comparator data signal “alarm bells” for UK Governmen... Latest UK Life Sciences Competitive Indicators “ought to ring alarm bells across Government,” says ABPI.
Market Access Philips on designing innovation and cultivating partnerships... Sachin Grover, lead of solutions vertical at Philips India, tells me about the company's innovations during India's COVID outbreak and how they've led to increased healthcare access in the
News Lily gets FDA nod for SERD-CDK 4/6 combo in breast cancer Eli Lilly's imlunestrant (Inluriyo) for breast cancer has received a new FDA approval, in combination with CDK4/6 inhibitor abemaciclib (Verzenio).
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
